Literature DB >> 15905265

Using antibiotics in suspected haemolytic-uraemic syndrome: antibiotics should not be used in Escherichia coli O157:H7 infection.

Stephanie Dundas, W T Andrew Todd, Marguerite A Neill, Phillip I Tarr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15905265      PMCID： PMC558027          DOI： 10.1136/bmj.330.7501.1209

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Use of antibiotics in suspected haemolytic-uraemic syndrome.

Authors:  Bob Phillips; Kay Tyerman; Simon M Whiteley
Journal:  BMJ       Date:  2005-02-19

2.  Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.

Authors:  K Ikeda; O Ida; K Kimoto; T Takatorige; N Nakanishi; K Tatara
Journal:  Clin Nephrol       Date:  1999-12       Impact factor: 0.975

3.  Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.

Authors:  Nasia Safdar; Adnan Said; Ronald E Gangnon; Dennis G Maki
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272
  3 in total
  5 in total

Review 1.  Clostridium septicum myonecrosis complicating diarrhea-associated hemolytic uremic syndrome.

Authors:  Tracy E Hunley; Michele D Spring; Timothy R Peters; Douglas R Weikert; Kathy Jabs
Journal:  Pediatr Nephrol       Date:  2008-02-27       Impact factor: 3.714

2.  Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7.

Authors:  Si-Ying Wu; Gil-Yong Park; So-Hee Kim; John Hulme; Seong Soo A An
Journal:  Drug Des Devel Ther       Date:  2016-10-14       Impact factor: 4.162

3.  Prophage induction, but not production of phage particles, is required for lethal disease in a microbiome-replete murine model of enterohemorrhagic E. coli infection.

Authors:  Sowmya Balasubramanian; Marcia S Osburne; Haley BrinJones; Albert K Tai; John M Leong
Journal:  PLoS Pathog       Date:  2019-01-10       Impact factor: 6.823

4.  Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity.

Authors:  James W Collins; Ali R Akin; Artemis Kosta; Ning Zhang; Mark Tangney; Kevin P Francis; Gad Frankel
Journal:  Microbiology (Reading)       Date:  2012-08-17       Impact factor: 2.777

Review 5.  Management of hemolytic-uremic syndrome in children.

Authors:  Silviu Grisaru
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.